Cobra cardiotoxin and phospholipase A2 as GAG-binding toxins: On the path from structure to cardiotoxicity and inflammation

Trends in Cardiovascular Medicine

Volumn 8, Issue 6, 1998, Pages 270-278

  Wu, Wen Guey ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

COBROTOXIN; FIBRONECTIN; GLYCOSAMINOGLYCAN; PHOSPHOLIPASE A2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD CLOTTING; CARDIOTOXICITY; CELL PROLIFERATION; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; SHORT SURVEY; TOXIN STRUCTURE;

EID: 0031688881     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(98)00019-X     Document Type: Article

References (88)

1. 2. Molecular cloning, identification of a secreted soluble form: expression and chromosomal localization. J Biol Chem 270:8963-8970.
2. 2 in Swiss 3T3 cells via specific binding site. J Biol Chem 266:19139-19144.
3. 2: a structural review. Toxicon 34:827-841.
4. Barkalow FJB, Schwarzbauer JE: 1991. Localization of the major heparin-binding site in fibronectin. J Biol Chem 266:7812-7818.
5. Batenburg AM, Bougis PE, Rochat H, Verkleij AJ, de Kruijff B: 1985. Penetration of cardiotoxin into cardiolipin model membranes and its implication on lipid organization. Biochemistry 24:7101-1110.
6. Bernfield M, Kokenyesi R, Kato M, et al.: 1992. Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Ann Rev Cell Biol 8:365-393.
7. Bilwes A, Rees B, Moras D, Menez R, Menez A: 1994. X-ray structure at 1.55 Å of toxin γ, a cardiotoxin from Naja nigricollis venom: crystal packing reveals a model for insertion into membranes. J Mol Biol 239: 122-136.
8. Bourin MC, Lindahl U: 1993. Glycosaminoglycans and the regulation of blood coagulation. Biochem J 289:313-330.
9. Brunton TL, Payer J: 1873. On the nature and physiology action of the poison of Naja tripudians and other Indian venomous snakes. Part I. Proc R Soc Lond 21:358-374.
10. Brunton TL, Fayer J: 1874. On the nature and physiology action of the poison of Naja tripudians and other Indian venomous snakes. Part II. Proc R Soc Lond 22:68-133.
11. Busby TF, Argraves WS, Brew SA, Pechik I, Gilliland GL, Ingham KC: 1995. Heparin binding by fibronectin module III-13 involves six discontinuous basic residues brought together to form a cationic cradle. J Biol Chem 270:18558-18562.
12. Chang CC: 1979. The action of snake venoms on nerve and muscle. In Lee CY, ed. Snake Venoms. Handbook of Experimental Pharmacology, Vol. 52. Berlin, Springer-Verlag, pp 309-375.
13. Chiang CM, Chien KY, Lin HJ, et al.: 1996a. Conformational change and inactivation of membrane phospholipid-related activity of cardiotoxin V from Taiwan cobra venom at acidic pH. Biochemistry 35:9167-9176.
14. Chiang CM, Chang SL, Lin HL, Wu W: 1996b. The role of acidic amino acid residues in the structural stability of snake cardiotoxins. Biochemistry 35:9177-9186.
15. Chien KY, Huang WN, Jean JH, Wu W: 1991. Fusion of sphingomyelin vesicles induced by proteins from Taiwan cobra (Naja naja atra) venom. J Biol Chem 266:3252-3259.
16. Chien KY, Chiang CM, Hseu YC, Vyas AA, Rule GS, Wu W: 1994. Two distinct types of cardiotoxins as revealed by the structure and activity relationship of their interaction with zwitterionic phospholipid dispersions. J Biol Chem 269:14473-14483.
17. 2 from cobra venom with cytotoxic properties not related to esterase. J Biol Chem 264:13289-13297.
18. 2 from Naja nigricollis venom. Biochim Biophys Acta 1045:285-290.
19. Czubayko F, Liaudet-Coopman EDE, Aigner A, Tuveson AT, Berchem GJ, Wellstein A: 1997. A secreted FGF-binding protein can serve as the angiogenic switch in human cancer. Nature Med 3:1137-1140.
20. DeGrendele HC, Estess P, Siegelman MH: 1997. Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science 278:672-675.
21. 2. J Biol Chem 269:13057-13060.
22. 2, anticoagulant and myotoxic activity. Biochem Biophys Acta 1070:455-460.
23. 2 to phospholipid micelles: importance of the amino-terminus. Biochemistry 30:9090-9097.
24. Dijke PT, Miyazono K, Heldin CH: 1996. Signalling via hetero-oligomeric complexes of type I and type II serine/threonine kinase receptors. Curr Opin Cell Biol 8:139-145.
25. 2 by heparin. Eur J Biochem 221:481-490.
26. Dufton MJ, Hider RC: 1991. The structure and pharmacology of Elapid cytotoxins. In Harvey AL, ed. Snake Toxins. New York, Pergamon Press, pp 259-302.
27. Elgavish S, Shaanan B: 1997. Lectin-carbohydrate interactions: different folds, common recognition principles. Trends Biochem Sci 22:462-467.
28. Engelberg H: 1996. Actions of heparin in the atherosclerotic process. Pharmacol Rev 48: 327-352.
29. Faham S, Hileman RE, Fromm JR, Lindart RJ, Rees DC: 1996. Heparin structure and interactions with basic fibroblast growth factor. Science 271:1116-1120.
30. Faller B, Mely Y, Gerard D, Bieth JG: 1992. Heparin-induced conformational change and activation of mucus proteinase inhibitor. Biochemistry 31:8285-8290.
31. Fletcher JE, Jiang MS: 1993. Possible mechanism of action of cobra snake venom cardiotoxins and bee venom mellitin. Toxicon 31:669-695.
32. Fried M, Duffy PE: 1996. Adherence of plasmodium falciparum to chondroitin sulfate A in the human placenta. Science 272: 1502-1504.
33. Han SK, Yoon ET, Scott DL, Stigler PB, Cho W: 1997. Structural aspects of interfacial adsorption: a crystallographic and site-directed mutagenesis study of the phospholipase A2 from the venom of Agkistrodon Piscivorus Piscivorus. J Biol Chem 272:3573-3582.
34. Hanasaki K, Yokota Y, Ishizaki J, Itoh T, Arita H: 1997. Resistance to endotoxic shock in phospholipase A2 receptor-deficient mice. J Biol Chem 272:32792-32797.
35. Harvey AL: 1991. Cardiotoxins from cobra venoms. In Tu AT, ed. Reptile Venoms and Toxins. New York, Marcel Dekker, pp 85-106.
36. Heldin CH: 1995. Dimerization of cell surface receptors in signal transduction. Cell 80: 213-223.
37. Herr AB, Ornitz DM, Sasiekharan R, Venkataraman G, Waksman G: 1997. Heparin-induced self-association of fibroblast growth factor-2: evidence for two oligomerization process. J Biol Chem 272:16382-16389.
38. Hoogewerf AJ, Kuschert GSV, Proudfoot AEI, et al.: 1997. Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry 36:13570-13578.
39. Jang JY, Kumar TKS, Jayaraman G, Yang PW, Yu C: 1997. Comparison of the hemolytic activity and solution structures of two snake venom cardiotoxin analogues which only differ in their N-terminal amino acid. Biochemistry 36:14635-14641.
40. Kitagawa H, Tsutsumi K, Tone Y, Sugahara K: 1997. Developmental regulation of the sulfation profile of chondroitin sulfate chains in the chicken embryo brain. J Biol Chem 272:31377-31381.
41. Kjellen L, Lindahl LA: 1991. Proteoglycans: structure and interaction. Ann Rev Biochem 60:443-475.
42. Kostiza T, Meier J: 1996. Nerve growth factors from snake venoms: chemical properties, mode of action and biological significance. Toxicon 34:787-806.
43. Lee CY, Lee SY: 1979. Cardiovascular effect of snake venoms. In Lee CY, ed. Snake Venoms. Handbook of Experimental Pharmacology, Vol. 52. Berlin, Springer-Verlag, pp 546-590.
44. 2. J Biol Chem 272:16709-16712.
45. Lindahl U, Lidholt K, Spillmann D, Kjellen L: 1994. More to heparin than anticoagulation. Thrombosis Res 75:1-32.
46. Liu YS: 1997. The interaction of cobra venom components with phospholipid membrane as studied by Langmuir minitrough. MS thesis, National Tsing Hua University Hsinchu, Taiwan.
47. 2 from Bothrops asper snake venom. J Biol Chem 269:29867-29873.
48. Maimone MM, Tollefsen DM: 1990. Structure of a dermatan sulfate hexasaccharide that binds to heparin cofactor II with high affinity. J Biol Chem 265:18263-18271.
49. 2 comparison of arachidonoyl-selective and nonselective enzymes. FASEB J 7:339-348.
50. Meagher JM, Huntington JA, Fan B, Gettins PGW: 1996. Role of Arg-132 and Lys-133 in heparin binding to and activation of antithrombin. J Biol Chem 271:29353-29358.
51. Middleton J, Nei S, Wintle J, et al.: 1997. Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell 91:385-395.
52. Moy FJ, Safran M, Seddon AP, et al.: 1997 Properly oriented heparin-decasaccharide-induced dimers are the biologically active form of basic fibroblast factor. Biochemistry 36:4782-4791.
53. 2. Crit Rev Immunol 17:225-283.
54. Ownby CL, Fletcher JE, Coleberg TR: 1993. Cardiotoxin I from cobra (Naja naja atra) venom causes necrosis of skeletal muscle in vivo. Toxicon 31:697-709.
55. Patel HV, Vyas AA, Vyas KA, Chiang CM, Chi LM, Wu W: 1997. Heparin and heparan sulfate bind to snake cardiotoxins: sulfated oligosaccharides as a potential target for cardiotoxin action. J Biol Chem 272:1484-1493.
56. Pedersen JZ, de Arcuri BF, Morero RD, Rufini S: 1994. Phospholipase-like myotoxins induce rapid membrane leakage of non-hydrolyzable ether-lipid liposomes. Biochim Biophys Acta 1190:177-180.
57. Rak J, Kerbel RS: 1997. bFGF and tumor angiogenesis: back in the limelight? Nature Med 3:1083-1084.
58. Rees B, Bilwes A: 1993. Three-dimensional structures of neurotoxins and cardiotoxins. Chem Res Toxicol 6:385-406.
59. Rollins BJ: 1997. Chemokines. Blood 90:909-928.
60. 2. In Shier WT, Mebs D, eds. Handbook of Toxicology. New York, Marcel Dekker, pp 67-277.
61. Rufini S, Cesaroni P, Desideri A, et al.: 1992. Calcium ion independent membrane leakage induced by phopholipase-like myotoxins. Biochemistry 31:12424-12430.
62. Ruoslahti E: 1988. Fibronectin and its receptors. Ann Rev Biochem 57:375-413.
63. Salmivirta M, Lidholt K, Lindahl U: 1996. Heparan sulfate: a piece of information. FASEB J 10:1270-1279.
64. 2 type II to proteoglycans: differential effect of glycosaminoglycans on enzymatic activity. J Biol Chem 271:26307-26314.
65. Scott JE: 1992. Morphometry of cupromeronic blue-stained proteoglycan molecules in animal corneas, versus that of purified proteoglycans stained in vitro, implies that tertiary structures contribute to corneal ultrastructure. J Anatomy 180:155-164.
66. 2. Biophys J 67:493-504.
67. 2. Adv Protein Chem 45:53-88.
68. Singhal AK, Chien KY, Wu W, Rule RS: 1993. Solution structure of cardiotoxin V from Naja naja atra. Biochemistry 32:8036-8044.
69. 2. Biochemistry 36:14325-14333.
70. Spillmann D, Lindahl U: 1994. Glycosaminoglycans-protein interactions: a question of specificity. Curr Opinion Struc Biol 4:677-682.
71. Spivak-Kroizman T, Lemmon MA, Dikic I: 1994. Heparin-induced oligomerization of FGF molecules is responsible for FGF dimerization, activation and cell proliferation. Cell 79:1015-1024.
72. 2 from Naja nigricollis venom inhibits the prothrombinase complex by a novel nonenzymatic mechanism. Biochemistry 29:7742-7746.
73. Stringer SE, Gallagher JT: 1997. Specific binding of the chemokine platelet factor 4 to heparan sulfate. J Biol Chem 272:20508-20514.
74. Sue S, Rajan PK, Chen TS, Hsieh CH, Wu W: 1997. Action of Taiwan cobra cardiotoxin on membrane: binding modes of a β-sheet polypeptide with phosphatidylcholine bilayers. Biochemistry 36:9826-9836.
75. Sun JJ, Walker MJA: 1986. Action of cardiotoxins from the southern Chinese cobra (Naja naja atra) on rat cardiac tissue. Toxicon 24:233-245.
76. Sun YJ, Wu W, Chiang CM, Hsin AY, Hsiao CD: 1997. The crystal structure of cardiotoxin V from Taiwan cobra venom: pH-dependent conformational changes and a novel membrane spanning motif formed by the three-finger loops of P-type cardiotoxins. Biochemistry 36:2403-2413.
77. 2 gene family in mammals. J Biol Chem 272:17247-17250.
78. Van Boeckel CAA, Petitou M: 1993. The unique antithrombin III binding domain of heparin: lead to new synthetic antithrombotics. Angew Chem Int Ed 32:1771-1818.
79. Volpi N, Cusmano M, Venturelli T: 1995. Qualitative and quantitative studies of heparan and chondroitin sulfates in normal human plasma. Biochim Biophys Acta 1243:49-58.
80. Vyas AA, Pan JJ, Patel HV, et al.: 1997. Analysis of binding of cobra cardiotoxins reveals a new β-sheet heparin-binding structural motif. J Biol Chem 272:9661-9670.
81. Vyas KA, Patel HV, Vyas AA, Wu W: 1998. Glycosaminoglycans bind to homogeneous cardiotoxins with different specificity. Biochemistry. 37:4527-4534.
82. Wight TN, Heinegard DK, Hascall VC: 1991. Proteoglycans: structure and function. In Hay ED, ed. Cell Biology of Extracellular Matrix, 2nd ed. New York, Plenum Press, p 45.
83. Witt DP, Lander AD: 1994. Differential binding of chemokines to glycosaminoglycan subpopulations. Current Biol 4:394-400.
84. Wong P, Hampton B, Szylobryt E, Gallagher AM, Jaye M, Burgess WH: 1995. Analysis of putative heparin-binding domains of fibroblast growth factor 1 using site directed mutagenesis and peptide analogues. J Biol Chem 270:25805-25811.
85. Wu W: 1997. Diversity of cobra cardiotoxins. J Toxicol Toxin Rev 16:115-134.
86. Wu W, Li Y, Szabo G: 1993. Ionic basis for the action of cobra snake cardiotoxins [abst]. FASEB J 7:A1235.
87. 2 on the heart: electrophysiological evidence for altered G-protein function through enzymatic activity [abst]. Biophys J 66:A433.
88. Yanagishita M, Hascall VC: 1992. Cell surface heparan sulfate proteoglycans. J Biol Chem 267:9451-9454.